Meta facebook tracking pixel
Subscribe to these results:

Past Workshops

  1. Breast Cancer in Younger Women: New Treatment Options
  2. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
  3. The Benefits of Clinical Trials for Triple Negative Breast Cancer
  4. Updates from the 46th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer
  5. Living with Breast Cancer - 46th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
  6. Metastatic Triple Negative Breast Cancer: For Caregivers - Coping with Your Loved One's Triple Negative Breast CancerPart II of Living with Metastatic Triple Negative Breast Cancer
  7. 2023 American Society of Clinical Oncology (ASCO) Annual Meeting: Triple Negative Breast Cancer Research Updates
  8. Metastatic Triple Negative Breast Cancer: Strategies to CopePart I of Living with Metastatic Triple Negative Breast Cancer
  9. Triple Negative Breast Cancer and African American Women
  10. Metastatic Breast Cancer: Treatment Updates
  11. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
  12. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
  13. Early Stage Breast Cancer: New Treatment Approaches
  14. What’s New in Precision Medicine
  15. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
  16. Lobular Breast Cancer: Treatment Progress
  17. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
  18. Updates in the Treatment of Estrogen Receptor (ER), Progesterone Receptor (PR) and HER2 Positive Breast Cancer from the 45th Annual San Antonio Breast Cancer SymposiumPart II of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
  19. Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
  20. Living with Breast Cancer – Updates from the 45th San Antonio Breast Cancer Symposium (SABCS)Part I of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
  21. What’s New In Precision Medicine
  22. For Caregivers: Coping with Your Loved One’s Metastatic Triple Negative Breast CancerPart II of Living with Metastatic Triple Negative Breast Cancer
  23. The Benefits of Clinical Trials for Triple Negative Breast Cancer
  24. Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
  25. Triple Negative Breast Cancer and African American Women
  26. Metastatic Breast Cancer: Treatment Updates
  27. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
  28. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
  29. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
  30. The Role of Radiation Therapy in the Treatment of Breast Cancer
  31. Metastatic Breast Cancer in African Americans: New Treatments
  32. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
  33. Updates from the 44th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
  34. What’s New in Diagnostic Technologies for People Living with Solid Cancer TumorsPart I of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
  35. The Latest Developments Reported at the 44th Annual San Antonio Breast Cancer Symposium (SABCS)Part I of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
  36. Metastatic Triple Negative Breast Cancer: For Caregivers, Coping with Your Loved One’s CancerPart II of Living with Triple Negative Breast Cancer
  37. The Benefits of Clinical Trials for Triple Negative Breast Cancer
  38. Triple Negative Breast Cancer and African American Women
  39. HER2-Positive Metastatic Breast Cancer: New Therapies
  40. Metastatic Breast Cancer: Treatment Updates
  41. Metastatic Triple Negative Breast Cancer: Strategies to CopePart I of Living with Triple Negative Breast Cancer
  42. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
  43. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart I of Equity. Every Patient. Every Day. Everywhere.
  44. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
  45. Caregiving for Your Loved One Living with Metastatic Triple Negative Breast CancerPart II of Life with Metastatic Triple Negative Breast Cancer
  46. The Benefits of Clinical Trials for Triple Negative Breast Cancer
  47. Triple Negative Breast Cancer and Fear of Recurrence
  48. Triple Negative Breast Cancer and African American Women
  49. Coping with the Stresses of Caregiving When Your Loved One Has Triple Negative Breast CancerPart III of Living with Triple Negative Breast Cancer
  50. Breast Cancer and Older Women
Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.